Literature DB >> 22743645

Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites.

A Kanatas1, N Ghazali, D Lowe, M Udberg, J Heseltine, E O'Mahony, S N Rogers.   

Abstract

PURPOSE: The patient concerns inventory (PCI) was developed to help patients raise issues/concerns during routine follow-up and to indicate team members they want to see. This paper reports the use of the PCI across various H&amp;N Cancer sub-sites (oral, oropharyngeal and laryngeal) and stages of disease (early and late) and describes the main concerns that patients want to discuss using a cross-sectional survey comprising the PCI with the University of Washington Quality of Life questionnaire. Patients treated for primary H&amp;N squamous cell carcinoma, 1998-2009, were identified from the University Hospital Aintree H&amp;N Cancer database. 447/775 (58 %) patients responded. Fear of recurrence concerns was common to all clinical groups (range 32-67 %). Speech issues were more common with laryngeal tumours, and saliva issues with oropharyngeal tumours (32 % early, 48 % late). Apart from early-stage laryngeal tumours, patients consistently reported issues concerning dental health/teeth and chewing. The median (IQR) number of concerns overall was 4 (2-7), with significant variation (p < 0.001) between clinical groups ranging from 2 (1-6) for early-stage oral to 6 (2-10) for late-stage oropharyngeal and 7 (5-9) late-stage laryngeal. The results indicated that PCI can be readily incorporated into managing HNC patients and supports a holistic multidisciplinary approach to clinic consultations. It accommodates difficult issues such as fear of recurrence and intimacy. Completion of the PCI by patients before consultation can highlight problems and concerns that doctors can target for discussion, thereby streamlining consultations, and ensuring that patient needs are better met, thus creating a more effective service.

Entities:  

Mesh:

Year:  2012        PMID: 22743645     DOI: 10.1007/s00405-012-2092-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Measuring quality of life: Using quality of life measures in the clinical setting.

Authors:  I J Higginson; A J Carr
Journal:  BMJ       Date:  2001-05-26

2.  Treatment referral before and after the introduction of the Liverpool Patients Concerns Inventory (PCI) into routine head and neck oncology outpatient clinics.

Authors:  Naseem Ghazali; Anastasios Kanatas; Daniel J R Langley; Barry Scott; Derek Lowe; Simon N Rogers
Journal:  Support Care Cancer       Date:  2011-07-03       Impact factor: 3.603

3.  Head and neck cancer patients' perspective of carer burden.

Authors:  E Precious; S Haran; D Lowe; S N Rogers
Journal:  Br J Oral Maxillofac Surg       Date:  2012-04       Impact factor: 1.651

4.  Fear of recurrence following head and neck cancer in the outpatient clinic.

Authors:  S N Rogers; B Scott; D Lowe; G Ozakinci; G M Humphris
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-27       Impact factor: 2.503

Review 5.  Routinely administered questionnaires for depression and anxiety: systematic review.

Authors:  S M Gilbody; A O House; T A Sheldon
Journal:  BMJ       Date:  2001-02-17

6.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

Review 7.  A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005.

Authors:  S N Rogers; S A Ahad; A P Murphy
Journal:  Oral Oncol       Date:  2007-06-27       Impact factor: 5.337

8.  A guide of the questionnaires used in the measurement of health-related quality of life in head and neck oncology.

Authors:  Anastasios N Kanatas; Simon N Rogers
Journal:  Tumori       Date:  2008 Sep-Oct

Review 9.  Needs assessment for cancer patients and their families.

Authors:  Kuang-Yi Wen; David H Gustafson
Journal:  Health Qual Life Outcomes       Date:  2004-02-26       Impact factor: 3.186

10.  How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?

Authors:  W Söllner; A DeVries; E Steixner; P Lukas; G Sprinzl; G Rumpold; S Maislinger
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more
  15 in total

1.  Assessing quality of life in patients after partial laryngectomy.

Authors:  F Hebel; K Mantsopoulos; C Bohr
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

2.  The impact of pre-radiotherapy dental extractions on head and neck cancer patients: a qualitative study.

Authors:  S Clough; M Burke; B Daly; S Scambler
Journal:  Br Dent J       Date:  2018-06-22       Impact factor: 1.626

3.  A single-item screening question for fear of recurrence in head and neck cancer.

Authors:  Simon N Rogers; Ben Cross; Cyrus Talwar; Derek Lowe; Gerry Humphris
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-07       Impact factor: 2.503

4.  Characteristics and referral of head and neck cancer patients who report chewing and dental issues on the Patient Concerns Inventory.

Authors:  R Mahmood; C Butterworth; D Lowe; S N Rogers
Journal:  Br Dent J       Date:  2014-06-13       Impact factor: 1.626

5.  Can post-treatment oral cancer patients' concerns reflect their cancer characteristics, HRQoL, psychological distress level and satisfaction with consultation?

Authors:  Ainon Natrah Aminnudin; Jennifer Geraldine Doss; Siti Mazlipah Ismail; Ma Bee Chai; Marzuki Zainal Abidin; Cri Saiful Jordan Milano Basri; Nurshaline Pauline Kipli; Lee Chee Wei
Journal:  Ecancermedicalscience       Date:  2020-10-08

6.  Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.

Authors:  Ryan P Goepfert; Jan S Lewin; Martha P Barrow; C David Fuller; Stephen Y Lai; Juhee Song; Brian P Hobbs; G Brandon Gunn; Beth M Beadle; David I Rosenthal; Adam S Garden; Merrill S Kies; Vali A Papadimitrakopoulou; David L Schwartz; Katherine A Hutcheson
Journal:  Laryngoscope       Date:  2016-07-21       Impact factor: 3.325

7.  Health related quality of life following the treatment of oropharyngeal cancer by transoral laser.

Authors:  S N Rogers; R S Pinto; J Lancaster; F Bekiroglu; D Lowe; S Tandon; T M Jones
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-18       Impact factor: 2.503

8.  Routine Use of Swallowing Outcome Measures Following Head and Neck Cancer in a Multidisciplinary Clinic Setting.

Authors:  Annette C Zuydam; Simon N Rogers; Kate Grayson; Clare F Probert
Journal:  Int Arch Otorhinolaryngol       Date:  2020-06-23

9.  Is social inequality related to different patient concerns in routine oral cancer follow-up clinics?

Authors:  Sarah Allen; Derek Lowe; Rebecca V Harris; Steve Brown; Simon N Rogers
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-22       Impact factor: 2.503

10.  Variations in concerns reported on the patient concerns inventory in patients with head and neck cancer from different health settings across the world.

Authors:  Simon N Rogers; Alvaro Alvear; Alexandre Anesi; Emmanuel Babin; Ali Balik; Martin Batstone; Phillipp Brockmeyer; Claudia Celedon Carrasco; Chih-Yen Chien; Magdalena Chirila; Kanchan P Dholam; Jennifer G Doss; Caterina Finizia; Wan M Nabilah Ghani; Sandeep V Gurav; Kathreena Kadir; Mateusz Kolator; Roberto Lima; Yu-Tsai Lin; Simon Nhongo; Meltem Ozdemir-Karatas; Kadriye Peker; Zoran Pesic; Pierre Ransy; Izabella Santos; Henning Schliephake; Ketan Shah; Fernanda Souza; Geethu Sunil; Krishnakumar Thankappan; Ylva Tiblom Ehrsson; Cristina Tiple; Lisa Tuomi; Sara Valerini; Pablo Vasquez Lara; Tomasz Zatoński; Derek Lowe
Journal:  Head Neck       Date:  2019-12-13       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.